News

With over three decades of experience across India, ASEAN, and Australia, Deepali Naair brings deep expertise in brand ...
Naair will lead Biocon Biologics' global brand and corporate communications strategy as part of its executive team, reporting ...
India’s Dr Reddy’s Laboratories Ltd. is gearing up to launch a generic version of semaglutide — the active ingredient in Novo ...
Biocon Biologics appoints Deepali Naair as Global Head of Brand & Corporate Communications. She brings 30+ years experience ...
Biocon Biologics has appointed Deepali Naair as the global head of brand and corporate communications. Naair, with three ...
Bengaluru: Biocon Biologics Limited, a fully integrated global biosimilars company and a subsidiary of Biocon Limited, has ...
Nepexto will be promoted by Generic Health, BBL's local partner and a leading provider of high-quality generic prescription, ...
Biocon's subsidiary, Biocon Biologics, has introduced Nepexto, a biosimilar to Enbrel (Etanercept), in Australia for treating ...
Biocon Biologics Limited (BBL), a fully integrated global biosimilars company and a subsidiary of Biocon Limited today ...
The shares of biopharmaceutical firm Biocon fell as much as 2.04 per cent in Tuesday's trading session, figuring among top ...
Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years ...